Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 ...
The treatment landscape of chronic lymphocytic leukaemia has undergone a revolution in the past decade. Highly effective ...
Phylo-Plex, a new computational method, has been developed by Wellcome Sanger Institute scientists and their collaborators to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results